Natixis Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.46M | Buy |
385,215
+52,292
| +16% | +$876K | 0.01% | 766 |
|
|
2025
Q1 | $5.12M | Sell |
332,923
-171,611
| -34% | -$2.64M | 0.01% | 815 |
|
|
2024
Q4 | $11.1M | Buy |
504,534
+335,667
| +199% | +$7.4M | 0.02% | 617 |
|
|
2024
Q3 | $3.04M | Sell |
168,867
-32,485
| -16% | -$585K | 0.01% | 965 |
|
|
2024
Q2 | $3.27M | Buy |
201,352
+43,373
| +27% | +$705K | 0.01% | 894 |
|
|
2024
Q1 | $2.23M | Buy |
+157,979
| New | +$2.23M | 0.01% | 1005 |
|
|
2017
Q1 | – | Sell |
-75,515
| Closed | -$2.74M | – | 1052 |
|
|
2016
Q4 | $2.74M | Sell |
75,515
-11,451
| -13% | -$415K | 0.03% | 591 |
|
|
2016
Q3 | $4M | Sell |
86,966
-12,723
| -13% | -$585K | 0.05% | 441 |
|
|
2016
Q2 | $5.01M | Sell |
99,689
-45,231
| -31% | -$2.27M | 0.07% | 366 |
|
|
2016
Q1 | $7.75M | Buy |
144,920
+3,413
| +2% | +$183K | 0.12% | 212 |
|
|
2015
Q4 | $9.29M | Sell |
141,507
-37,398
| -21% | -$2.45M | 0.15% | 163 |
|
|
2015
Q3 | $10.1M | Sell |
178,905
-77,758
| -30% | -$4.39M | 0.18% | 135 |
|
|
2015
Q2 | $15.2M | Sell |
256,663
-3,276
| -1% | -$194K | 0.26% | 76 |
|
|
2015
Q1 | $16.2M | Buy |
259,939
+28,656
| +12% | +$1.79M | 0.28% | 63 |
|
|
2014
Q4 | $13.3M | Buy |
231,283
+63,521
| +38% | +$3.65M | 0.25% | 79 |
|
|
2014
Q3 | $9.02M | Sell |
167,762
-44,257
| -21% | -$2.38M | 0.18% | 141 |
|
|
2014
Q2 | $11.1M | Buy |
212,019
+60,291
| +40% | +$3.16M | 0.16% | 184 |
|
|
2014
Q1 | $8.02M | Sell |
151,728
-13,360
| -8% | -$706K | 0.12% | 277 |
|
|
2013
Q4 | $6.62M | Sell |
165,088
-2,280
| -1% | -$91.4K | 0.11% | 309 |
|
|
2013
Q3 | $6.32M | Sell |
167,368
-9,037
| -5% | -$341K | 0.12% | 303 |
|
|
2013
Q2 | $6.92M | Buy |
+176,405
| New | +$6.92M | 0.14% | 254 |
|